WPATH, EPATH, USPATH, AsiaPATH, CPATH, AusPATH, and PATHA Response to Bell v. Tavistock Judgment
[Update 5/4/2021: This statement has been developed into a paper that was published in the International Journal of Transgender Health. It is available on the WPATH website here. The authors note “the current paper is an extended version of that statement including the scientific evidence and references which the necessary brevity of such policy statements precludes”.]
[Update 1/1/2021: AusPATH have also released their own statement about this ruling which is available here.]
Statement Regarding Medical Affirming Treatment, Including Puberty Blockers for Transgender Adolescents
The Boards of Directors of the World Professional Association for Transgender Health (WPATH), the European Association for Transgender Health (EPATH), the United States Professional Association for Transgender health (USPATH), the Asia Professional Association for Transgender Health (AsiaPATH), the Canadian Association for Transgender Health (CPATH), the Australian Professional Association for Trans Health (AusPATH), and the Professional Association for Transgender Health Aotearoa (PATHA) all strongly disagree with the recent judgement of the London High Court in Bell v. Tavistock. We believe this decision will result in significant harm to the affected children and their families. We oppose this ruling and urge that this ruling be appealed and overturned.
